Results 41 to 50 of about 579,519 (167)
Esophageal and Esophagogastric Junction Cancers, Version 1.2015 [PDF]
Esophageal cancer is the sixth most common cause of cancer deaths worldwide. Adenocarcinoma is more common in North America and Western European countries, originating mostly in the lower third of the esophagus, which often involves the esophagogastric ...
Charles S. Fuchs +74 more
core +1 more source
Supplemental Material, sj-pdf-2-ccx-10.1177_10732748211066309 for Effect of Marital Status on the Survival of Patients With Adenocarcinoma of the Esophagogastric Junction: A Population-Based, Propensity-Matched Study by Sihan Wang, Liubo Chen, Dongdong ...
Dongdong Chen (415068) +6 more
core +1 more source
ABSTRACT MET is an actionable receptor tyrosine kinase, and MET‐directed antibody–drug conjugates (ADCs) have recently entered clinical practice with FDA approval in non‐small cell lung cancer and are now being evaluated across gastrointestinal malignancies, with patient selection based on MET immunohistochemistry (IHC) 3+ membranous staining at ...
Tillmann Bedau +7 more
wiley +1 more source
This comprehensive review summarizes gastric cancer epidemiology, multifactorial risk factors (like infectious, dietary, genetic), pathogenesis such as precancerous evolution, molecular alterations, and a focus on the bidirectional interactions between gastric cancer cells and macrophages in the tumor microenvironment.
Yixuan Xin +6 more
wiley +1 more source
ABSTRACT Background Non‐pathological complete response (non‐pCR) is common in esophageal squamous cell carcinoma (ESCC) patients after neoadjuvant therapy, yet evidence guiding long‐term outcomes and postoperative risk stratification in the immunotherapy era remains limited.
Weibin Liu +9 more
wiley +1 more source
Adenosquamous carcinoma of the esophagogastric junction. Case report [PDF]
Adenosquamous carcinoma is a rare tumor with coexisting elements of infiltrating squamous cell carcinoma and adenocarcinoma. This tumor is reported to arise in different organs but rarely in the oesophagus.
De Giacomo, Tiziano +7 more
core +1 more source
Background and Study Aims There are a few reports about the efficacy of endoscopic submucosal dissection (ESD) for adenocarcinomas of the esophagogastric junction (EGJ).
Yasuaki Nagami +13 more
doaj +1 more source
ABSTRACT Background Hypoalbuminemia has been recognized as a characteristic adverse event associated with zolbetuximab plus chemotherapy in the treatment of claudin 18.2‐positive advanced gastric cancer. However, its incidence, clinical predictors, and management in real‐world settings remain unclear.
Taro Mizuno +11 more
wiley +1 more source
Adenocarcinoma of the Esophagogastric Junction: Clinicopathological Characteristics. [PDF]
The incidence of adenocarcinoma of the esophagogastric junction (AEG) is dramatically increasing in Western countries, while it is not increasing in Eastern countries.
김지현
core
A case report of adenosquamous carcinoma of the esophagogastric junction
Background Many types of tumors can arise in the esophagogastric junction (EGJ). Squamous cell carcinoma (SCC) arising from the esophageal epithelia, adenocarcinoma arising from the gastric mucosa, or Barrett’s esophageal mucosa are frequently observed ...
Harunari Fukai +6 more
doaj +1 more source

